Libro blanco de las ACES Pediátricas 2024

Neumología Pediátrica. Anexos ❚ 659 b. Recognize the importance of travel history in the diagnosis of hemoptysis c. Understand the importance of identifying other organ involvement in patients with diffuse alveolar hemorrhage syndromes d. Recognize that retained foreign body is a common cause of massive hemoptysis in previously healthy children 2. Physical examination a. Recognize the clinical constellation of features characteristic of Goodpasture syndrome b. Recognize the physical findings associated with pulmonary hemorrhage 3. Imaging a. Recognize the radiographic features typical of diffuse alveolar hemorrhage 4. Pulmonary function tests a. Recognize the changes in pulmonary function associated with hemosiderosis (including diffusion capacity abnormalities) 5. Other investigations a. Understand the role of bronchoalveolar lavage in diagnosing alveolar hemorrhage b. Understand the limitations of identifying hemosiderin-laden macrophages in bronchoalveolar lavage in the diagnosis of alveolar hemorrhage syndromes c. Recognize the laboratory findings suggestive of immune- mediated lung disease in a child with pulmonary bleeding d. Recognize that a negative antineutrophil cytoplasmic antibody (ANCA) test does not exclude a diagnosis of pulmonary capillaritis e. Understand the role of cardiac and renal function testing and coagulation studies in evaluating patients with alveolar hemorrhage syndromes f. Understand the role of lung biopsy in the diagnosis of alveolar hemorrhage syndromes e. Prevention and therapeutic approach 1. Prevention 2. Therapeutic approach a. Know the treatment for massive pulmonary bleeding in a child b. Know the treatment for Goodpasture syndrome c. Know the current approaches to the treatment of a child with idiopathic pulmonary hemosiderosis d. Know the current approaches to the treatment for pulmonary capillaritis 3. Side effects of therapy a. Understand the risks associated with selective bronchial artery embolization in the treatment of pulmonary hemorrhage f. Prognosis 1. Know the natural history of idiopathic pulmonary hemosiderosis is highly variable 2. Know the time course for radiographic resolution of pulmonary hemorrhage 3. Know the natural history of pulmonary bleeding associated with immune- mediated lung disease 4. Know the natural history of pulmonary hemorrhage associated with bronchiectasis in patients with cystic fibrosis